Literature DB >> 18957178

Neuroimaging of disorders leading to dementia.

Joseph C Masdeu1, Belen Pascual.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18957178     DOI: 10.1007/s11910-008-0069-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  19 in total

1.  Clinical manifestations of cerebral amyloid angiopathy-related inflammation.

Authors:  Jessica A Eng; Matthew P Frosch; Kyungchan Choi; G William Rebeck; Steven M Greenberg
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

2.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

3.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Authors:  Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

Review 4.  Neuroimaging as a marker of the onset and progression of Alzheimer's disease.

Authors:  Jose C Masdeu; Jose L Zubieta; Javier Arbizu
Journal:  J Neurol Sci       Date:  2005-09-15       Impact factor: 3.181

5.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Authors:  Keith A Johnson; Matt Gregas; John A Becker; Catherine Kinnecom; David H Salat; Erin K Moran; Erin E Smith; Jonathan Rosand; Dorene M Rentz; William E Klunk; Chester A Mathis; Julie C Price; Steven T Dekosky; Alan J Fischman; Steven M Greenberg
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

6.  Cognitive impact of subcortical vascular and Alzheimer's disease pathology.

Authors:  Helena C Chui; Chris Zarow; Wendy J Mack; William G Ellis; Ling Zheng; William J Jagust; Dan Mungas; Bruce R Reed; Joel H Kramer; Charles C Decarli; Michael W Weiner; Harry V Vinters
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

7.  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D S Knopman; S T DeKosky; J L Cummings; H Chui; J Corey-Bloom; N Relkin; G W Small; B Miller; J C Stevens
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

8.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

9.  Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.

Authors:  A Viswanathan; A Gschwendtner; J-P Guichard; F Buffon; R Cumurciuc; M O'Sullivan; M Holtmannspötter; C Pachai; M-G Bousser; M Dichgans; H Chabriat
Journal:  Neurology       Date:  2007-07-10       Impact factor: 9.910

10.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

View more
  1 in total

1.  A 42-year-old woman with subacute reversible dementia: A cautionary tale.

Authors:  Joseph Kamtchum-Tatuene; Richard Kamwezi; Thokozani Nyalubwe; Josephine P Banda; Gloria Mwangalika; Ian Matandika; Ulla Hemmila; Magnus Tisell; Susanna Koponen; Laura A Benjamin; Patrick Kamalo
Journal:  Malawi Med J       Date:  2017-09       Impact factor: 0.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.